EN PL
ORIGINAL PAPER
Relevance of application of the Yamaguchi criteria for patients with suspected juvenile idiopathic arthritis in the absence of arthritis symptoms
 
More details
Hide details
 
Submission date: 2014-10-31
 
 
Acceptance date: 2014-11-04
 
 
Online publication date: 2014-11-29
 
 
Publication date: 2014-12-31
 
 
Reumatologia 2014;52(6):362-368
 
KEYWORDS
TOPICS
ABSTRACT
Aim of the study: Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation beside arthritis. Many children may have delayed onset of arthritis. We aimed in our study to determine whether the Yamaguchi criteria (for adult onset Still’s disease) can be applied in diagnosis of sJIA, especially in absence of arthritis.
Material and methods: The cross-sectional study included 30 patients diagnosed with sJIA, those patients diagnosed by the treating paediatrician with ‘definite’ sJIA (fulfilling the International League of Associations for Rheumatology [ILAR] classification criteria) or ‘suspected’ sJIA (not fulfilling the ILAR criteria). The fulfilment of the variables in both the ILAR criteria and the Yamaguchi criteria was recorded for each patient at the time of first presentation.
Results: We included 16 boys and 14 girls. Ten patients were diagnosed with suspected sJIA due to the presence of typical systemic features but failed to fulfil the ILAR criteria, especially absence of arthritis in 9 of them. Yamaguchi criteria were fulfilled in a higher number of patients (23/30, 76.7%) as compared to those who fulfilled the ILAR criteria (20/30, 66.7%). All 10 patients with suspected sJIA fulfilled the Yamaguchi criteria, and 11 patients (36.7%) had delayed onset of arthritis. Overall, the 30 patients (100%) in the present study fulfilled either ILAR criteria or Yamaguchi criteria.
Conclusions: There is a subgroup of patients with sJIA in whom arthritis is absent or delayed. The use of the Yamaguchi criteria in this subgroup of patients may be useful for early diagnosis and treatment of sJIA. Thus, further studies are needed to integrate supplementary criteria that increase the strength of both the Yamaguchi and the ILAR criteria.
 
REFERENCES (29)
1.
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369: 767-778. .
 
2.
Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis. Baillieres Clin Rheumatol 1998; 12: 245-271. .
 
3.
Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology (Oxford) 2005; 44: 1350-1353. .
 
4.
Kumar S, Kunhiraman DS, Rajam L. Application of Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA). Pediatr Rheumatol Online J 2012; 10: 40-48. .
 
5.
De Benedetti F, Schneider R. Systemic juvenile idiopathic arthritis. In: Textbook of Pediatric Rheumatology. 6th ed. Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds.). Elsevier, Philadelphia 2011: 236-248. .
 
6.
Petty RE, Southwood TR, Manners P, et al. International League of Association for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392. .
 
7.
Vastert S, De Jager W, Noordman BJ, et al. Anakinra in the early phase of systemic onset JIA: before the onset of arthritis. Ann Rheum Dis 2011; 70 (Suppl 3): 408. .
 
8.
Cabane J, Michon A, Ziza JM, et al. Comparison of long term evolution of adult onset and juvenile onset Still’s disease, both followed up for more than 10 years. Ann Rheum Dis 1990; 49: 283-285. .
 
9.
Lin SJ, Chao HC, Yan DC. Different articular outcomes of Still’s disease in Chinese children and adults. Clin Rheumatol 2000; 19: 127-130. .
 
10.
Luthi F, Zufferey P, Hofer MF, So AK. Adolescent-onset Still’s disease: characteristics and outcome in comparison with adult-onset Still’s disease. Clin Rheumatol 2002; 20: 427-430. .
 
11.
Uppal SS, Pande IR, Kumar A, et al. Adult onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 1995; 19: 424-430. .
 
12.
Tanaka S, Matsumoto Y, Ohnishi H, et al. Comparison of clinical features of childhood and adult onset Still’s disease. Ryumachi 1991; 31: 511-518. .
 
13.
Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol 1992; 19: 424-430. .
 
14.
Masson C, Le Loet X, Liote F, et al. Comparative study of 6 types of criteria in adult Still’s disease. J Rheumatol 1996; 23: 495-497. .
 
15.
Maeno N, Takei S, Nomura Y, et al. Highly elevated serum levels of interleukin 18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum 2002; 46: 2539-2541. Author replay 2541-2542. .
 
16.
de Jager W, Vastert SJ, Beekman JM, et al. Defective phosphorylation of interleukin-18 receptor B causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arhtritis Rheum 2009; 60: 2782-2793. .
 
17.
Donn RP, Shelley E, Ollier WE, Thomson W. For the British Paediatric Rheumatology Study Group: A novel 5’-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782-1785. .
 
18.
Meazza C, Travaglino P, Pignatti P, et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 232-237. .
 
19.
Frosch M, Ahlmann M, Vogl T, et al. The myloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1 beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 883-891. .
 
20.
Holzinger D, Frosch M, Kastrup A, et al. The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic onset juvenile idiopathic arthritis. Ann Rheum Dis 2012; 71: 974-980. .
 
21.
Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-971. .
 
22.
Wittkowski H, Frosch M, Wulffraat N, et al. S100A12 is a novel molecular marker differentiating systemic – onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum 2008; 58: 3924-3931. .
 
23.
de Jager W, Hoppenreijs EP, Wulffraat NM, et al. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross sectional study. Ann Rheum Dis 2007; 66: 589-598. .
 
24.
Pay S, Türkçapar N, Kalyoncu M, et al. A multicentre study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006; 25: 639-644. .
 
25.
Behrens EM, Beukelman T, Gallo L, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol 2008; 35: 343-348. .
 
26.
DeWitt EM, Kimura Y, Beukelman T, et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1001-1010. .
 
27.
Modesto C, Woo P, García-Consuegra J, et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol 2001; 19: 211-217. .
 
28.
Seth V, Kabra SK, Semwal OP, Jain Y. Clinicoimmunological profile in juvenile rheumatoid arthritis – an indian experience. Indian J Pediatr 1996; 63: 293-300. .
 
29.
Singh S, Salaria M, Kumar L, et al. Clinicoimmunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr 1999; 36: 449-454.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top